GleamWall
中文EN

OPHI CollPlant Biotechnologies Ltd

Orthopedic, Prosthetic & Surgical Appliances & Supplies · Nasdaq · SEC CIK 1631487 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY360.4%
TTM net income YoY30.8%
TTM EPS YoY35.2%
Revenue 3-yr CAGR99.4%
Net income 3-yr CAGR—

Margins

Gross margin64.8%
Operating margin-484.3%
Net margin-484.6%
FCF margin-398.4%
EBITDA margin-445.8%

Returns

ROE-117.6%
ROA-77.9%
ROIC (approx.)-886.8%
Asset turnover0.16x

Leverage & solvency

Liabilities / assets43.6%
Debt / equity0.00x
Current ratio2.53x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.82x
Accruals ratio-14.0%
Payout ratio—
Capex / revenue1.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2025Q22025-06-302024Q22024-06-302023Q22023-06-302022Q22022-06-302021Q22021-06-302020Q22020-06-302019Q22019-06-302018Q2*2018-06-30
Income statement
Revenue$179,000$249,000$10.18M$66,000$691,000$823,000$606,000$182,000
Cost of revenue$186,000$536,000$615,000$43,000$429,000$748,000$463,000$67,000
Gross profit-$7,000-$287,000$9.57M$23,000$262,000$75,000$143,000$115,000
R&D expense$2.01M$2.70M$2.57M$2.60M$1.90M$1.00M$1.08M$641,000
SG&A expense$1.16M$1.42M$1.32M$1.61M$1.42M$986,000$820,000$863,000
Operating income-$3.18M-$4.41M$5.68M-$4.18M-$3.06M-$1.91M-$1.76M-$1.39M
Interest expense——————$64,000$247,000
Net income-$3.35M-$4.21M$5.76M-$4.29M-$3.04M-$1.97M-$1.25M-$1.55M
EPS (basic)0.280.370.51-0.39-0.30-0.280.270.36
EPS (diluted)0.280.370.49-0.39-0.30-0.280.270.36
Weighted avg. shares (diluted)11.84M11.45M11.78M11.09M10.20M6.96M4.66M—
Balance sheet
Cash & equivalents$11.43M$18.92M$22.28M$36.29M$17.68M$3.85M$1.91M$2.56M
Receivables—$250,000$10.16M$9,000$277,000$321,000$611,000$423,000
Inventory$553,000$439,000$1.55M$1.36M$940,000$730,000$958,000$642,000
Current assets$12.62M$20.34M$34.86M$38.27M$49.77M$5.49M$3.61M$4.22M
PP&E, net$1.86M$2.56M$2.93M$2.92M$2.12M$2.25M$2.24M$1.48M
Intangibles$102,000$159,000$216,000$235,000$164,000———
Total assets$17.44M$26.57M$41.57M$44.41M$55.02M$10.95M$9.55M$6.26M
Current liabilities$2.74M$3.24M$2.78M$2.36M$2.93M$2.18M$3.30M$1.07M
Long-term debt———————$58,000
Total debt———————$58,000
Total liabilities$4.93M$5.84M$5.53M$4.91M$5.58M$5.17M$7.72M$2.71M
Shareholders' equity$12.51M$20.73M$36.04M$39.51M$49.44M$5.78M$764,000$3.54M
Net debt———————-$2.51M
Shares outstanding12.72M11.45M11.41M10.77M10.26M6.47M——
Cash flow statement
Operating cash flow————————
Stock-based compensation$356,000$490,000$338,000——$477,000$289,000—

Free plan shows the latest 8 periods; Pro shows all 9 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.